The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate
Open accessAbstract
Cardiac hypertrophy occurs in up to 95% of patients with CKD and increases their risk for cardiovascular death. In the kidney, full-length membranous Klotho forms the coreceptor for fibroblast growth factor 23 (FGF23) to regulate phosphate metabolism. The prevailing view is that the decreased level of Klotho in CKD causes cardiomyopathy through increases in serum FGF23 and/or phosphate levels. However, we reported recently that soluble Klotho protects against cardiac hypertrophy by inhibiting abnormal calcium signaling in the heart. Here, we tested whether this protective effect requires changes in FGF23 and/or phosphate levels. Heterozygous Klotho-deficient CKD mice exhibited aggravated cardiac hypertrophy compared with wild-type CKD mice. Cardiac magnetic resonance imaging studies revealed that Klotho-deficient CKD hearts had worse functional impairment than wild-type CKD hearts. Normalization of serum phosphate and FGF23 levels by dietary phosphate restriction did not abrogate the aggravated cardiac hypertrophy observed in Klotho-deficient CKD mice. Circulating levels of the cleaved soluble ectodomain of Klotho were lower in wild-type CKD mice than in control mice and even lower in Klotho-deficient CKD mice. Intravenous delivery of a transgene encoding soluble Klotho ameliorated cardiac hypertrophy in Klotho-deficient CKD mice. These results suggest that the decreased level of circulating soluble Klotho in CKD is an important cause of uremic cardiomyopathy independent of FGF23 and phosphate, opening new avenues for treatment of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Regulation of the Voltage Gated K+ Channel Kv1.3 by Recombinant Human Klotho Protein
Almilaji, A., Honisch, S., Liu, G., Elvira, B., Ajay, S. S., Hosseinzadeh, Z., Ahmed, M., Munoz, C., Sopjani, M., & Lang, F. (2014) · Kidney and Blood Pressure Research · doi:10.1159/000368472 · Cited by 5,592
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Self-citationBlock, G., Hulbert-Shearon, T., Levin, N., & Port, F. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9531176 · Cited by 2,354
FGF23 induces left ventricular hypertrophy
Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46122 · Cited by 2,027
Self-citationSuppression of Aging in Mice by the Hormone Klotho
Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., et al. (2005) · Science · doi:10.1126/science.1112766 · Cited by 1,935
Self-citationKlotho converts canonical FGF receptor into a specific receptor for FGF23
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2006) · Nature · doi:10.1038/nature05315 · Cited by 1,850
Shimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeuchi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., & Yamashita, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19081 · Cited by 1,596
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
White, K. E., Evans, W. E., O'Riordan, J. L. H., Speer, M. C., Econs, M. J., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T., & Strom, T. M. (2000) · Nature Genetics · doi:10.1038/81664 · Cited by 1,528
Regulation of Fibroblast Growth Factor-23 Signaling by Klotho
Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Baum, M. G., Schiavi, S., Hu, M.-C., Moe, O. W., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500457200 · Cited by 1,366
Self-citationSerum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
Kestenbaum, B., Sampson, J. N., Rudser, K. D., Patterson, D. J., Seliger, S. L., Young, B., Sherrard, D. J., & Andress, D. L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070602 · Cited by 1,226
Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
Hu, M. C., Shi, M., Zhang, J., Quiñones, H., Griffith, C., Kuro-o, M., & Moe, O. W. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121311 · Cited by 926
Self-citationHypertrophy of the Heart: A New Therapeutic Target?
Frey, N., Katus, H. A., Olson, E. N., & Hill, J. A. (2004) · Circulation · doi:10.1161/01.cir.0000120390.68287.bb · Cited by 851
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Gutiérrez, O. M., Januzzi, J. L., Isakova, T., Laliberte, K., Smith, K., Collerone, G., Sarwar, A., Hoffmann, U., Coglianese, E., Christenson, R., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.844506 · Cited by 837
Augmented Wnt signaling in a mammalian model of accelerated aging
Liu, H., Fergusson, M. M., Castilho, R. M., Liu, J., Cao, L., Chen, J., Malide, D., Rovira, I. I., Schimel, D., Kuo, C. J., et al. (2007) · Science · doi:10.1126/science.1143578 · Cited by 755
Fliser, D., Kollerits, B., Neyer, U., Ankerst, D. P., Lhotta, K., Lingenhel, A., Ritz, E., & Kronenberg, F. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080936 · Cited by 699
The ß-Glucuronidase Klotho Hydrolyzes and Activates the TRPV5 Channel
Chang, Q., Hoefs, S., van der Kemp, A. W., Topala, C. N., Bindels, R. J., & Hoenderop, J. G. (2005) · Science · doi:10.1126/science.1114245 · Cited by 622
Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule
Hu, M. C., Shi, M., Zhang, J., Pastor, J., Nakatani, T., Lanske, B., Razzaque, M. S., Rosenblatt, K. P., Baum, M. G., Kuro‐O, M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-154765 · Cited by 578
Self-citationTRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling
Kuwahara, K., Wang, Y., McAnally, J., Richardson, J. A., Bassel-Duby, R., Hill, J. A., & Olson, E. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27702 · Cited by 561
Imura, A., Iwano, A., Tohyama, O., Tsuji, Y., Nozaki, K., Hashimoto, N., Fujimori, T., & Nabeshima, Y.-I. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.090 · Cited by 534
Severely Reduced Production of Klotho in Human Chronic Renal Failure Kidney
Koh, N., Fujimori, T., Nishiguchi, S., Tamori, A., Shiomi, S., Nakatani, T., Sugimura, K., Kishimoto, T., Kinoshita, S., Kuroki, T., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4226 · Cited by 494
The FGF23–Klotho axis: endocrine regulation of phosphate homeostasis
Razzaque, M. S. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.196 · Cited by 448
Shalhoub, V., Shatzen, E. M., Ward, S. C., Davis, J., Stevens, J., Bi, V., Renshaw, L., Hawkins, N., Wang, W., Chen, C., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61405 · Cited by 413
Cha, S.-K., Ortega, B., Kurosu, H., Rosenblatt, K. P., Kuro-o, M., & Huang, C.-L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803223105 · Cited by 412
Self-citationUpdate on fibroblast growth factor 23 in chronic kidney disease
Wolf, M. (2012) · Kidney International · doi:10.1038/ki.2012.176 · Cited by 391
α-Klotho as a Regulator of Calcium Homeostasis
Imura, A., Tsuji, Y., Murata, M., Maeda, R., Kubota, K., Iwano, A., Obuse, C., Togashi, K., Tominaga, M., Kita, N., et al. (2007) · Science · doi:10.1126/science.1135901 · Cited by 384
Loss of Klotho Contributes to Kidney Injury by Derepression of Wnt/β-Catenin Signaling
Zhou, L., Li, Y., Zhou, D., Tan, R. J., & Liu, Y. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012080865 · Cited by 374
Left Ventricular Mass in Chronic Kidney Disease and ESRD
Glassock, R. J., Pecoits-Filho, R., & Barberato, S. H. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04860709 · Cited by 352
Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart
Xie, J., Cha, S.-K., An, S.-W., Kuro-o, M., Birnbaumer, L., & Huang, C.-L. (2012) · Nature Communications · doi:10.1038/ncomms2240 · Cited by 329
Self-citationKlotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism
Kuro-o, M. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.111 · Cited by 255
Self-citationAlpha-Klotho as a regulator of calcium homeostasis
Tsuji, Y. (2008) · Kyoto University Research Information Repository (Kyoto University) · Cited by 241
Yoshida, T., Fujimori, T., & Nabeshima, Y.-I. (2002) · Endocrinology · doi:10.1210/endo.143.2.8657 · Cited by 240
Cardiorenal Syndrome: The Emerging Role of Protein-Bound Uremic Toxins
Lekawanvijit, S., Kompa, A. R., Wang, B. H., Kelly, D. J., & Krum, H. (2012) · Circulation Research · doi:10.1161/circresaha.112.278457 · Cited by 183
Gross, M., & Ritz, E. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2008.00454.x · Cited by 162
The Progression of Aging in Klotho Mutant Mice Can Be Modified by Dietary Phosphorus and Zinc
Morishita, K., Kubota, M., Katakura, Y., Kamiya, T., Shirai, A., Nabeshima, Y.-I., & Takeshige, K. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.12.3182 · Cited by 161
The emerging role of Klotho in clinical nephrology
Hu, M. C., Kuro‐o, M., & Moe, O. W. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs160 · Cited by 146
Self-citationVascular calcification and hypertension: Cause and effect
Kalra, S. S., & Shanahan, C. M. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.660498 · Cited by 138
Control of Cardiac Growth and Function by Calcineurin Signaling
Vega, R. B., Bassel‐Duby, R., & Olson, E. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300023200 · Cited by 132
Hypertension, left ventricular hypertrophy and chronic kidney disease
Taddei, S., Nami, R., Bruno, R. M., Quatrini, I., & Nuti, R. (2010) · Heart Failure Reviews · doi:10.1007/s10741-010-9197-z · Cited by 112
Partial nephrectomy as a model for uremic cardiomyopathy in the mouse
Kennedy, D. J., Elkareh, J., Shidyak, A., et al. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00472.2007 · Cited by 111
Liu, Z., Xie, J., Wu, T., Truong, T., Auchus, R. J., & Huang, C.-L. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq525 · Cited by 99
Self-citationLaboratory aspects of circulating -Klotho
Heijboer, A. C., Blankenstein, M. A., Hoenderop, J. G. J., de Borst, M. H., & Vervloet, M. G. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft236 · Cited by 94
Serum level of soluble (pro)renin receptor is modulated in chronic kidney disease
Hamada, K., Taniguchi, Y., Shimamura, Y., Inoue, K., Ogata, K., Ishihara, M., Horino, T., Fujimoto, S., Ohguro, T., Yoshimoto, Y., et al. (2013) · Clinical and Experimental Nephrology · doi:10.1007/s10157-013-0803-y · Cited by 88
The Antisenescence Protein Klotho Is Necessary for FGF23-Induced Phosphaturia
Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., & Yamashita, T. (2007) · Journal of the American Society of Nephrology · doi:10.1681/01.asn.0000926868.48235.3d · Cited by 63
Fibroblast Growth Factor–23 and Cardiac Structure and Function
Agarwal, I., Ide, N., Ix, J. H., Kestenbaum, B. R., Lanske, B., Schiller, N. B., Whooley, M. A., & Mukamal, K. J. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000584 · Cited by 58
Uremic Cardiomyopathy and Insulin Resistance: A Critical Role for Akt?
Semple, D. J., Smith, K., Bhandari, S., & Seymour, A. L. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009090900 · Cited by 58
Rowell, J., Koitabashi, N., & Kass, D. A. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9208-4 · Cited by 52
Fibroblast growth factor 23: friend or foe in uremia?
Moe, O. W. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64184 · Cited by 21
Cited by
Cardiovascular disease in dialysis patients
Cozzolino, M., Mangano, M., Stucchi, A., Ciceri, P., Conte, F., & Galassi, A. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy174 · Cited by 564
Zoccali, C., Vanholder, R., Massy, Z. A., Ortiz, A., Sarafidis, P., Dekker, F. W., Fliser, D., Fouque, D., Heine, G. H., Jager, K. J., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.52 · Cited by 444
Hu, M. C., Shi, M., Gillings, N., Flores, B., Takahashi, M., Kuro-o, M., & Moe, O. W. (2017) · Kidney International · doi:10.1016/j.kint.2016.10.034 · Cited by 263
Self-citationPathophysiology of calcium, phosphorus, and magnesium dysregulation in chronic kidney disease
Felsenfeld, A. J., Levine, B. S., & Rodriguez, M. (2015) · Seminars in Dialysis · doi:10.1111/sdi.12411 · Cited by 189
Chuppa, S., Liang, M., Liu, P., Liu, Y., Casati, M. C., Cowley, A. W., Patullo, L., & Kriegel, A. J. (2018) · Kidney International · doi:10.1016/j.kint.2017.05.014 · Cited by 99
Metadata
- Authors
- Xie, J., Yoon, J., An, S.-W., Kuro-o, M., & Huang, C.-L.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2015-05
- Volume
- 26
- Issue
- 5
- Pages
- 1150-1160
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2127915809
- Cited by
- 263
- References
- 50
- FWCI
- 14.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.